OrbiMed Genesis GP LLC — SEC insider filings

SEC reporting owner CIK 1808744. 91 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers the 50 most recent of 91 filings on record, filed 2023-05-08 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enliven Therapeutics, Inc. (ELVN)10% owner4—8 legs · 2,174,831 sh · $74,560,2962
Disc Medicine, Inc. (IRON)Director73 legs · 83,334 sh · $3,000,02439 legs · 939,675 sh · $52,696,5622
Braveheart Bio, Inc. (BRVE)Director, 10% owner12 legs · 1,940,000 sh · $34,920,000—2
ALPINE IMMUNE SCIENCES, INC. (ALPN)Director3—6 legs · 1,546,347 sh · $28,671,7344
Electra Therapeutics, Inc. (ETRA)Director, 10% owner318 legs · 1,898,020 sh · $24,349,642—8
ADARx Pharmaceuticals, Inc. (ADRX)Director, 10% owner13 legs · 950,000 sh · $16,150,000—16
Adicet Bio, Inc. (ACET)10% owner49 legs · 9,000,000 sh · $14,328,7504 legs · 104,658 sh · $674,847—
Q32 Bio Inc. (QTTB)Director, 10% owner12 legs · 1,875,000 sh · $15,000,000——
Edgewise Therapeutics, Inc. (EWTX)Director, 10% owner23 legs · 951,316 sh · $14,999,995——
MBX Biosciences, Inc. (MBX)Director, 10% owner26 legs · 940,672 sh · $14,020,756—5

+11 more issuers among the filings shown — every filing appears in the table below.

Insider filings — OrbiMed Genesis GP LLC

FiledFormIssuerReported transactionsSource
2026-11-104Electra Therapeutics, Inc. (ETRA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Purchase (P): 9,816 @ $7.85 · Purchase (P): 39,600 @ $7.85 · Purchase (P): 4,000 @ $8.24 · Purchase (P): 16,000 @ $8.24 · Purchase (P): 20,700 @ $8.45 · Purchase (P): 2,000 @ $8.45EDGAR
2026-11-054Electra Therapeutics, Inc. (ETRA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Purchase (P): 24,313 @ $7.84 · Purchase (P): 97,800 @ $7.84 · Purchase (P): 24,400 @ $7.88 · Purchase (P): 98,600 @ $7.88 · Purchase (P): 9,267 @ $7.78 · Purchase (P): 37,100 @ $7.78 · +4 moreEDGAR
2026-09-304ADARx Pharmaceuticals, Inc. (ADRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Conversion (C): 10,690,530 · Conversion (C): 2,000,962 · Conversion (C): 769,601 · Conversion (C): 564,187 · Purchase (P): 300,249 @ $17 · Conversion (C): 7,127,019 · +13 moreEDGAR
2026-09-234Electra Therapeutics, Inc. (ETRA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Conversion (C): 2,002,310 · Conversion (C): 1,087,934 · Conversion (C): 1,703,314 · Purchase (P): 333,333 @ $15 · Conversion (C): 758,279 · Purchase (P): 1,000,000 @ $15 · +4 moreEDGAR
2026-08-114Braveheart Bio, Inc. (BRVE)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC
Conversion (C): 9,132,420 · Purchase (P): 1,666,667 @ $18 · Purchase (P): 273,333 @ $18 · Conversion (C): 40,000,000 (derivative) @ $0EDGAR
2026-06-244Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Sale (S): 24,846 @ $45.38 · Sale (S): 1,477 @ $45 · Sale (S): 787,024 @ $45.38 · Sale (S): 46,776 @ $45EDGAR
2026-06-174Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Sale (S): 9,086 @ $45.02 · Sale (S): 272,322 @ $45.02EDGAR
2026-06-154Shattuck Labs, Inc. (STTK)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC
Purchase (P): 1,041,667 (derivative) · Purchase (P): 208,333 (derivative)EDGAR
2026-06-094Shattuck Labs, Inc. (STTK)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC
Conversion (C): 15,366,490 (derivative) · Conversion (C): 3,073,298 (derivative) · Conversion (C): 15,366,490 (derivative) · Conversion (C): 3,073,298 (derivative)EDGAR
2026-06-014Q32 Bio Inc. (QTTB)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Purchase (P): 1,250,000 @ $8 · Purchase (P): 625,000 @ $8EDGAR
2026-04-234Prelude Therapeutics Inc (PRLD)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, ORBIMED CAPITAL LLC
Purchase (P): 1,689,189 @ $4.44 · Purchase (P): 1,126,126 @ $4.44EDGAR
2026-04-164ImageneBio, Inc. (IMA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Purchase (P): 336,603 (derivative) · Purchase (P): 384,689 (derivative)EDGAR
2026-04-094Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Sale (S): 29,319 @ $6.53 · Sale (S): 2,400 @ $6.38 · Sale (S): 32,523 @ $6.29 · Sale (S): 40,416 @ $6.52EDGAR
2025-12-184Keros Therapeutics, Inc. (KROS)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Disposition to issuer (D): 140,057 @ $17.75 · Disposition to issuer (D): 74,465 @ $17.75EDGAR
2025-10-104Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Purchase (P): 1,500,000 @ $1 · Purchase (P): 3,500,000 @ $1EDGAR
2025-09-024Shattuck Labs, Inc. (STTK)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC
Purchase (P): 5,255,106 @ $0.87 · Purchase (P): 1,051,021 @ $0.87 · Purchase (P): 10,111,384 (derivative) · Purchase (P): 2,022,277 (derivative) · Purchase (P): 15,366,490 (derivative) · Purchase (P): 3,073,298 (derivative)EDGAR
2025-07-304ImageneBio, Inc. (IKNA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Grant/award (A): 83,611 @ $2.49EDGAR
2025-04-114Compass Therapeutics, Inc. (CMPX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Sale (S): 3,571,428 @ $1.59EDGAR
2025-04-044Edgewise Therapeutics, Inc. (EWTX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Purchase (P): 372,578 @ $20.13 · Purchase (P): 124,193 @ $20.13EDGAR
2025-03-264Disc Medicine, Inc. (IRON)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC
Sale (S): 1,956 @ $54.11 · Sale (S): 3,026 @ $54.11 · Sale (S): 756 @ $54.11EDGAR
2025-03-214Disc Medicine, Inc. (IRON)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC
Sale (S): 13,517 @ $54.02 · Sale (S): 20,911 @ $54.02 · Sale (S): 5,228 @ $54.02 · Sale (S): 941 @ $54.01 · Sale (S): 1,457 @ $54.01 · Sale (S): 364 @ $54.01 · +3 moreEDGAR
2025-03-124Disc Medicine, Inc. (IRON)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC
Sale (S): 68,766 @ $54.29 · Sale (S): 106,384 @ $54.29 · Sale (S): 26,596 @ $54.29 · Sale (S): 136 @ $55.01 · Sale (S): 211 @ $55.01 · Sale (S): 53 @ $55.01 · +9 moreEDGAR
2025-02-194MBX Biosciences, Inc. (MBX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Purchase (P): 17,962 @ $9.90 · Purchase (P): 29,540 @ $9.85 · Purchase (P): 49,070 @ $10.84 · Purchase (P): 94,100 @ $10.84EDGAR
2024-09-174MBX Biosciences, Inc. (MBX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Conversion (C): 2,658,428 · Conversion (C): 403,787 · Purchase (P): 500,000 @ $16 · Purchase (P): 250,000 @ $16 · Conversion (C): 12,372,634 (derivative) · Conversion (C): 19,587,284 (derivative) · +1 moreEDGAR
2024-08-154scPharmaceuticals Inc. (SCPH)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Purchase (P): 478,342 @ $4 · Purchase (P): 21,658 @ $4EDGAR
2024-08-154Keros Therapeutics, Inc. (KROS)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Sale (S): 220,600 @ $44.01 · Sale (S): 29,400 @ $44.01EDGAR
2024-07-174Terns Pharmaceuticals, Inc. (TERN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Asia GP III, L.P., OrbiMed Advisors III Ltd
Sale (S): 39,433 @ $10 · Sale (S): 5,401 @ $10 · Sale (S): 6,142 @ $10 · Sale (S): 4,009 @ $10 · Sale (S): 556 @ $10 · Sale (S): 623 @ $10EDGAR
2024-06-204Disc Medicine, Inc. (IRON)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC
Purchase (P): 28,404 @ $36 · Purchase (P): 43,944 @ $36 · Purchase (P): 10,986 @ $36EDGAR
2024-05-204Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Sale (S): 33,300 @ $22.14 · Sale (S): 1,000,000 @ $22.14EDGAR
2024-05-204ALPINE IMMUNE SCIENCES, INC. (ALPN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Code (U): 2,416,181 · Code (U): 264,315EDGAR
2024-04-054Kinnate Biopharma Inc. (KNTE)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital GP VIII LLC, OrbiMed Asia GP IV, L.P., OrbiMed Advisors IV Ltd, ORBIMED CAPITAL LLC
Disposition to issuer (D): 1,368,339 · Disposition to issuer (D): 4,738,453 · Disposition to issuer (D): 1,368,338 · Disposition to issuer (D): 84,599 · Disposition to issuer (D): 450,000EDGAR
2024-02-144Theseus Pharmaceuticals, Inc. (THRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Code (U): 17,063,000 · Code (U): 650,600EDGAR
2024-01-264Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Purchase (P): 1,841,100 @ $2.40 · Purchase (P): 242,200 @ $2.40 · Purchase (P): 1,041,700 @ $2.40EDGAR
2024-01-254Edgewise Therapeutics, Inc. (EWTX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Purchase (P): 454,545 @ $11EDGAR
2024-01-164ALPINE IMMUNE SCIENCES, INC. (ALPN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Option exercise/expiry (X): 145,251 @ $12.74 · Option exercise/expiry (X): 145,251 (derivative) @ $0EDGAR
2023-12-294ALPINE IMMUNE SCIENCES, INC. (ALPN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Sale (S): 162,576 @ $19.96 · Sale (S): 18,922 @ $19.96 · Sale (S): 26,872 @ $19.82 · Sale (S): 3,128 @ $19.82 · Sale (S): 1,195,683 @ $18.32 · Sale (S): 139,166 @ $18.32EDGAR
2023-12-204Disc Medicine, Inc. (IRON)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC
Option exercise (M): 1,724 @ $38 · Sale (S): 1,724 @ $59.24 · Option exercise (M): 1,724 (derivative) @ $0EDGAR
2023-12-154Disc Medicine, Inc. (IRON)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC
Sale (S): 228,500 @ $56.75 · Sale (S): 147,600 @ $56.75 · Sale (S): 57,100 @ $56.75EDGAR
2023-12-144Disc Medicine, Inc. (IRON)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC
Sale (S): 14,400 @ $60.16 · Sale (S): 9,300 @ $60.16 · Sale (S): 3,600 @ $60.16 · Sale (S): 56,200 @ $58.56 · Sale (S): 36,400 @ $58.56 · Sale (S): 14,100 @ $58.56 · +2 moreEDGAR
2023-11-244PMV Pharmaceuticals, Inc. (PMVP)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC
Sale (S): 87,786 @ $2.23EDGAR
2023-09-214/AIkena Oncology, Inc. (IKNA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Grant/award (A): 153,121 · Grant/award (A): 353,192 (derivative)EDGAR
2023-09-144Ikena Oncology, Inc. (IKNA)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC
Grant/award (A): 153,121 · Grant/award (A): 353,192 (derivative)EDGAR
2023-08-174Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd, OrbiMed Capital GP VII LLC
Sale (S): 38,327 @ $0.75 · Sale (S): 248,819 @ $0.75 · Sale (S): 535,534 @ $0.75EDGAR
2023-08-024Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd, OrbiMed Capital GP VII LLC
Sale (S): 26,622 @ $3 · Sale (S): 29,700 @ $3 · Sale (S): 153,078 @ $3EDGAR
2023-07-274Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd, OrbiMed Capital GP VII LLC
Sale (S): 7,800 @ $2.92 · Sale (S): 4,700 @ $2.92 · Sale (S): 26,700 @ $2.92EDGAR
2023-07-194Theseus Pharmaceuticals, Inc. (THRX)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Purchase (P): 328,482 @ $3.05 · Purchase (P): 151,450 @ $3.05EDGAR
2023-07-174Galecto, Inc. (GLTO)
jointly with ORBIMED ADVISORS LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd, OrbiMed Capital GP VII LLC
Sale (S): 9,800 @ $2.40 · Sale (S): 52,800 @ $2.40 · Sale (S): 132,100 @ $2.40EDGAR
2023-06-294Adicet Bio, Inc. (ACET)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership, Chimovits Erez
Purchase (P): 125,000 @ $2.09 · Purchase (P): 250,000 @ $2.09 · Purchase (P): 442,000 @ $2.09 · Purchase (P): 58,000 @ $2.09EDGAR
2023-05-194Enliven Therapeutics, Inc. (ELVN)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC
Option exercise (M): 2,125 @ $4.28 · Option exercise (M): 2,125 (derivative) @ $0EDGAR
2023-05-084Kinnate Biopharma Inc. (KNTE)
jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital GP VIII LLC, OrbiMed Asia GP IV, L.P., OrbiMed Advisors IV Ltd, ORBIMED CAPITAL LLC
Purchase (P): 83,459 @ $2.75 · Purchase (P): 312,991 @ $2.75 · Purchase (P): 83,459 @ $2.75 · Purchase (P): 490,512 @ $2.82 · Purchase (P): 490,511 @ $2.82EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1808744 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs